Goldman Sachs
BLU

Goldman Sachs’s BELLUS Health Inc. BLU Stock Holding History

Goldman Sachs’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,413,933
Closed -$53.4M – 6216
2023
Q1 		$53.4M Sell
7,413,933
-665,207
-8% -$5.16M 0.01% 1027
2022
Q4 		$66.4M Buy
8,079,140
+882,090
+12% +$8.22M 0.02% 947
2022
Q3 		$76M Buy
7,197,050
+824,082
+13% +$8.76M 0.02% 828
2022
Q2 		$58.9M Buy
6,372,968
+47,901
+0.8% +$392K 0.01% 1005
2022
Q1 		$43.5M Buy
6,325,067
+6,181,546
+4,307% +$39.8M 0.01% 1395
2021
Q4 		$1.16M Buy
+143,521
New +$952K ﹤0.01% 4721
2021
Q3 		– Sell
-35,400
Closed -$110K – 6610
2021
Q2 		$110K Buy
+35,400
New +$135K ﹤0.01% 5921
2020
Q4 		– Sell
-100,357
Closed -$228K – 5789
2020
Q3 		$228K Buy
100,357
+62,517
+165% +$177K ﹤0.01% 4865
2020
Q2 		$389K Hold
37,840
– – ﹤0.01% 4504
2020
Q1 		$378K Buy
+37,840
New +$337K ﹤0.01% 4379
2019
Q4 		– Sell
-106,924
Closed -$683K – 5461
2019
Q3 		$683K Buy
+106,924
New +$754K ﹤0.01% 4274

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Goldman Sachs's BLU Position: Q2 2023 in Review

Goldman Sachs sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 7,413,933 shares — an estimated $53.4M sold.

Goldman Sachs first reported a position in BLU in Q3 2019 and held it in 11 quarters. The position peaked at $76M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Goldman Sachs reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 7,413,933 BELLUS Health Inc. shares in Q2 2023, an estimated $53.4M.
  • Goldman Sachs first reported a position in BELLUS Health Inc. in Q3 2019 and held it in 11 quarters.
  • Goldman Sachs's BELLUS Health Inc. position peaked at $76M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.